免疫信息学设计和体免疫原性评估的保存的CTL多位疫苗向HPV16E5,E6和E7蛋白质
Ni Guo1, Zhixin Niu1, Zhiling Yan2
1Yunnan Key Laboratory of Vaccine Research & Development on Severe Infectious Disease, Institute of Medical Biology, Chinese Academy of Medical Sciences & Peking Union Medical College, Kunming 650118, China.
Vaccines
|April 27, 2024
概括
一种针对人类乳头瘤病毒16型 (HPV16) E5,E6和E7蛋白质的新型多位疫苗在宫癌免疫治疗方面表现有前途. 这种疫苗表现出显著的抗瘤作用,并在临床前模型中提供了对瘤生长的完整保护.
科学领域:
- 免疫学 免疫学 免疫学
- 疫苗学 疫苗学 疫苗学
- 在瘤学瘤学.
背景情况:
- 人类乳头瘤病毒16型 (HPV16) 是全球宫癌的主要原因.
- 基于细胞毒性T淋巴细胞 (CTL) 表位的疫苗为治疗现有的HPV感染和宫癌提供了潜在的策略.
研究的目的:
- 设计和评估一种针对HPV16 E5,E6和E7蛋白的多表位疫苗,用于宫癌免疫治疗.
- 在临床前模型中评估开发疫苗的免疫性和抗瘤疗效.
主要方法:
- 利用免疫信息学方法预测HPV16 E5,E6和E7蛋白质的HLA-I受限制的CTL表位.
- 选和表征保存的CTL表位,然后在TC-1小鼠瘤模型中评估其免疫性和抗瘤作用,使用和复合蛋白疫苗.
主要成果:
- 多种表位疫苗在小鼠中诱导了抗原特异IFN-γ的分泌.
- 用两种疫苗配方进行预防性免疫接种,对瘤生长产生了100%的保护.
- 这两种疫苗类型都显著抑制了瘤生长,并在小鼠模型中延长了生存时间.
结论:
- 一种针对HPV16 E5,E6和E7蛋白质的多表位疫苗已成功设计和验证.
- 该疫苗在临床前研究中显示出显著的免疫性和强大的抗瘤作用.
- 这种方法为HPV相关瘤的免疫治疗提供了一个有希望的策略.
相关概念视频
Cancer Vaccines
359
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
359
Tumor Immunotherapy
520
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
520


